Environmental HealthMycotoxin Panel
Mycotoxin Testing: Mold Exposure & CIRS Guide
Clinical guide to mycotoxin testing and CIRS (Chronic Inflammatory Response Syndrome). Understand mold exposure testing, the MycoTOX panel, and treatment frameworks.
Sample: First Morning Urine•Clinical reference guide
Overview
Mycotoxins are toxic metabolites produced by molds. Exposure primarily occurs through inhalation (water-damaged buildings), ingestion (contaminated food), and skin contact. Chronic mycotoxin exposure can trigger CIRS (Chronic Inflammatory Response Syndrome) and has been linked to cancers, neurological conditions, and chronic inflammatory diseases. Testing measures mycotoxins being excreted in urine.
When to Order
- Suspected mold exposure (water-damaged building, visible mold)
- Chronic fatigue unresponsive to other treatments
- Brain fog, memory loss, cognitive decline
- Chronic respiratory issues (asthma, sinusitis, wheezing)
- Unexplained skin rashes
- Depression, anxiety, ADHD symptoms
- Chronic headaches/migraines
- Joint pain (mimics arthritis)
- Patients with genetic susceptibility (HLA-DR variants)
- Follow-up to monitor detoxification efficacy
- Vision changes (assess with VCS test)
MycoTOX Test — Mycotoxin Markers
| Mycotoxin | Mold Source | Health Effects |
|---|---|---|
| Aflatoxin M1 (AFM1) | Aspergillus flavus, A. parasiticus | Liver damage, liver cancer (Group 1 carcinogen), immune suppression |
| Ochratoxin A (OTA) | Aspergillus, Penicillium | Kidney damage, possible carcinogen, neurotoxic, immunotoxic |
| Sterigmatocystin (STG) | Aspergillus versicolor | Liver and kidney damage, precursor to aflatoxin |
| Roridin E | Stachybotrys (black mold), Myrothecium | Trichothecene — potent protein synthesis inhibitor |
| Verrucarin A | Stachybotrys, Myrothecium | Trichothecene — immune suppression, GI damage |
| Enniatin B1 | Fusarium | Mitochondrial toxin, antibiotic properties |
| Zearalenone (ZEA) | Fusarium | Estrogenic mycotoxin — mimics estrogen, reproductive effects |
| Gliotoxin | Aspergillus fumigatus | Potent immunosuppressant, destroys immune cells |
| Mycophenolic Acid | Penicillium | Immunosuppressant (basis for transplant drug mycophenolate) |
| Dihydrocitrinone | Penicillium, Aspergillus, Monascus | Kidney damage marker |
| Chaetoglobosin A | Chaetomium | Cytoskeletal disruption, cytotoxic |
CIRS (Chronic Inflammatory Response Syndrome) — Diagnostic Framework
Understanding CIRS
CIRS occurs when the immune system cannot properly process and eliminate biotoxins (including mycotoxins), leading to ongoing chronic inflammation. Approximately 25% of the population has HLA-DR gene variants making them susceptible.
Comprehensive CIRS Testing Protocol
| Test Category | Tests | Purpose |
|---|---|---|
| Mycotoxin Detection | MycoTOX, RealTime Mycotoxin Panel | Confirm mycotoxin presence |
| Visual Contrast Sensitivity (VCS) | Online VCS test | Neurological screening (non-invasive) |
| HLA-DR Genetic Testing | HLA-DR by PCR | Genetic susceptibility to biotoxin illness |
| Inflammatory Markers | C4a, TGF-β1, MMP-9 | Quantify ongoing inflammation |
| MSH (Melanocyte-Stimulating Hormone) | Serum MSH | LOW = hallmark of CIRS — immune dysregulation |
| MARCoNS | Nasal swab culture | Antibiotic-resistant staph in sinuses (common in CIRS) |
| ADH/Osmolality | Blood | Fluid regulation (often abnormal in CIRS) |
| VEGF | Blood | Vascular endothelial growth factor (often low in CIRS) |
| VIP | Blood | Vasoactive intestinal peptide (regulatory hormone) |
| Organic Acids Test | Urine OAT | Mitochondrial dysfunction from mycotoxin damage |
| EMMA | Environmental dust sample | Confirm mold in environment |
Inflammatory Marker Patterns in CIRS
| Marker | Expected in CIRS | Why |
|---|---|---|
| C4a | Elevated | Complement activation from biotoxin exposure |
| TGF-β1 | Elevated | Chronic immune activation, fibrosis risk |
| MMP-9 | Elevated | Tissue remodeling, blood-brain barrier disruption |
| MSH | Low | Immune dysregulation, sleep/pain/mood effects |
| VIP | Low | Regulatory failure |
| VEGF | Low | Impaired oxygen delivery |
| ADH/Osmolality | Abnormal | Polydipsia, dehydration |
Mycotoxin-Specific Clinical Patterns
Zearalenone (Estrogenic Mycotoxin)
- Mimics estrogen → can cause estrogen dominance symptoms
- Cross-reference with DUTCH estrogen metabolites
- Consider in patients with unexplained estrogen excess patterns
Ochratoxin A (Most Common Indoor Mycotoxin)
- Kidney damage — monitor renal function (BUN, creatinine, GFR)
- Neurotoxic — contributes to brain fog, cognitive issues
- Immunotoxic — suppresses immune function
- Cross-reference with OAT mitochondrial markers
Trichothecenes (Roridin E, Verrucarin A)
- From Stachybotrys (black mold) — most dangerous indoor mold
- Potent protein synthesis inhibitors
- Cause GI damage, immune suppression, bleeding disorders
- Cross-reference with CBC (immune cell counts)
Gliotoxin
- From Aspergillus fumigatus
- Destroys immune cells — can be profoundly immunosuppressive
- Cross-reference with immunoglobulin levels, WBC counts
Cross-References to Other Labs
| Mycotoxin Finding | Cross-Reference With |
|---|---|
| Any positive mycotoxin | OAT — mitochondrial markers (Krebs cycle) |
| Zearalenone positive | DUTCH — estrogen metabolites |
| Ochratoxin A positive | BMP — kidney function (BUN, creatinine) |
| Gliotoxin positive | CBC — immune cell counts, immunoglobulins |
| Multiple mycotoxins | HLA-DR genetic testing, inflammatory markers panel |
| High mycotoxins + fatigue | Thyroid panel, cortisol (adrenal assessment) |
| Environmental confirmation | EMMA test (dust sample from home/office) |
Treatment Framework (Post-Diagnosis)
Step 1: Environmental Remediation
- Critical: Cannot recover while ongoing exposure continues
- EMMA testing to confirm environmental source
- Professional mold remediation
- Consider HEPA air purifiers during remediation
Step 2: Binder Protocols
- Activated charcoal (broad spectrum)
- Cholestyramine (prescription — most studied for CIRS)
- Bentonite clay
- Modified citrus pectin
- Chlorella
- Note: Binders should be taken away from medications and supplements
Step 3: Liver/Detoxification Support
- Glutathione (liposomal or IV)
- NAC (glutathione precursor)
- Milk thistle
- Adequate hydration
- Sweating (sauna therapy)
Step 4: Anti-inflammatory Support
- Omega-3 fatty acids
- Curcumin
- SPMs (specialized pro-resolving mediators)
- Low-mold diet
Step 5: Monitoring
- Retest mycotoxins every 3-6 months
- Monitor inflammatory markers
- Track VCS scores
- Assess symptom improvement
Clinical Pearls
- Provocation increases sensitivity: Some practitioners use glutathione or sauna before collection to mobilize stored mycotoxins and increase urinary excretion
- Negative test ≠ no exposure: Poor detoxifiers may not excrete mycotoxins efficiently — low levels may paradoxically indicate inability to clear
- Always test the environment too: EMMA test confirms whether exposure is ongoing
- 25% of population is genetically susceptible: HLA-DR testing identifies these individuals
- Mold + OAT combo: The Myco-Metabolic Panel from Mosaic combines MycoTOX with OAT — shows both exposure AND metabolic damage
- Food-borne exposure: Coffee, grains, wine, dried fruits, nuts can contain mycotoxins — consider dietary sources
- Do NOT collect during menstruation — can affect results
- Stop certain medications 72 hours before collection
- Mycotoxins + mitochondria: Mycotoxins damage mitochondria → chronic fatigue is often the first symptom
mycotoxinsmoldCIRSMycoTOXOchratoxingliotoxindetoxification
Related Tests & Panels
Get Your Labs Analyzed
Lab Sage uses functional medicine optimal ranges to decode your lab results — going beyond conventional "normal" to show you what optimal health looks like.